Keymed Biosciences Inc. (2162)
Market Closed
2 Oct, 08:00 AM
HKEX 
78. 85
HKD -2.7
-3.3109%
11.21B Market Cap
- P/E Ratio
- Div Yield
490,000 Volume
0 Eps
81.55 HKD
Previous Close Want to track 2162 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Keymed Biosciences Inc. (2162) Statistics
Valuation metrics
Market Cap 11.21B
Enterprise value 18B
Trailing P/E (ttm) 23.95
Forward P/E -
PEG ratio -0.89
Price/Sales (ttm) 23.84
Price/Book (mrq) 4.71
Enterprise Value/Revenue 21.89
Enterprise Value/EBITDA -34.44
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.56M
Average volume (90 days) 2.25M
Price summary
52-Week low 44.66
52-Week high 89.75
Beta -
50-Day moving average 77.12
200-Day moving average 72.68
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.93%
Operating margin -0.75%
Operational effectiveness
Return on assets 0.13%
Return on equity 0.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.9
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.7
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.43
Total debt (mrq) -
Total Debt/Equity (mrq) 0.17
Current ratio (mrq) 4.83%
Book value per share (mrq) 14.13
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
